BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,037 filers reported holding BAXTER INTL INC in Q1 2015. The put-call ratio across all filers is 0.65 and the average weighting 0.4%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $19,610,000 | -8.9% | 227,765 | -14.1% | 0.18% | -7.7% |
Q1 2020 | $21,525,000 | -54.1% | 265,128 | -52.7% | 0.19% | -30.0% |
Q4 2019 | $46,899,000 | +14.9% | 560,865 | +20.2% | 0.28% | +16.9% |
Q3 2019 | $40,815,000 | +38.4% | 466,632 | +29.6% | 0.24% | +54.9% |
Q2 2019 | $29,486,000 | -19.3% | 360,028 | -19.9% | 0.15% | -19.0% |
Q1 2019 | $36,533,000 | -72.0% | 449,309 | -77.4% | 0.19% | -74.2% |
Q4 2018 | $130,673,000 | -52.1% | 1,985,312 | -43.9% | 0.73% | -43.2% |
Q3 2018 | $272,966,000 | -6.8% | 3,540,875 | -10.7% | 1.29% | -4.5% |
Q2 2018 | $292,771,000 | +12.6% | 3,964,942 | -0.8% | 1.35% | +13.5% |
Q1 2018 | $259,960,000 | -5.5% | 3,996,927 | -6.1% | 1.19% | +0.4% |
Q4 2017 | $275,055,000 | -3.2% | 4,255,177 | -6.0% | 1.18% | -4.0% |
Q3 2017 | $284,197,000 | -3.2% | 4,529,042 | -6.7% | 1.24% | -1.5% |
Q2 2017 | $293,729,000 | +159.8% | 4,851,819 | +122.5% | 1.25% | +168.5% |
Q1 2017 | $113,074,000 | +95.6% | 2,180,363 | +67.3% | 0.47% | +97.0% |
Q4 2016 | $57,798,000 | +328.5% | 1,303,508 | +360.0% | 0.24% | +308.6% |
Q3 2016 | $13,489,000 | +150.4% | 283,380 | +72.8% | 0.06% | +132.0% |
Q3 2015 | $5,386,000 | -63.9% | 163,962 | -23.1% | 0.02% | -60.9% |
Q2 2015 | $14,913,000 | +13.6% | 213,260 | +11.3% | 0.06% | +16.4% |
Q1 2015 | $13,123,000 | -15.8% | 191,570 | -9.9% | 0.06% | -16.7% |
Q4 2014 | $15,579,000 | +41.0% | 212,570 | +38.1% | 0.07% | +34.7% |
Q3 2014 | $11,050,000 | – | 153,960 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |